Treatment group:Cetuximab injection + capecitabine

2 trials

Sponsors

Xiyuan Hospital of CACMS

Conditions

Squamous cell carcinoma of head and neck

Unknown Phase

Clinical study of cetuximab combined with capecitabine in the treatment of recurrent or metastatic squamous cell carcinoma of head and neck in elderly or frail patients

Active, not recruitingChiCTR2400087711

Xiyuan Hospital of CACMSSquamous cell carcinoma of head and neck

Start: 2024-09-01Updated: 2024-08-05

Clinical study of cetuximab combined with capecitabine for maintenance of recurrent or metastatic head and neck squamous cell carcinoma

Active, not recruitingChiCTR2400087861

Xiyuan Hospital of CACMSSquamous cell carcinoma of head and neck

Start: 2024-09-01Updated: 2024-08-12